Status:
COMPLETED
Test of an Inhibitory Learning Model of Extinction in Treatment of Anxious Youth
Lead Sponsor:
University of Colorado, Denver
Conditions:
Anxiety Disorders
Eligibility:
All Genders
7-17 years
Phase:
NA
Brief Summary
Recently, basic research conducted in adults has revealed that fear extinction, or the weakening of a learned fear response, may be best explained by principles of "inhibitory learning." New guideline...
Detailed Description
Exposure therapy-which involves repeatedly exposing individuals to feared situations to change their fear responses to and beliefs about those situations--has been a mainstay of treatments for anxiety...
Eligibility Criteria
Inclusion
- Primary or secondary diagnosis of an anxiety disorder
- Ability of both child and caregiver to read and understand English
- Ability of child and at least one caregiver to attend weekly sessions
Exclusion
- Diagnosis of autism spectrum disorder, intellectual development disorder, or limited cognitive functioning (i.e., documented Intelligence Quotient \[IQ\]\<80).
- Diagnosis of a psychotic disorder or bipolar disorder
- Severe and current suicidal ideation, history of suicide attempt in past six months, or frequent and persistent self-injurious behavior
- Diagnosis of a substance use disorder or significant, recent substance use
- Any youth receiving concurrent individual therapy will also be excluded from the study.
Key Trial Info
Start Date :
January 31 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2020
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT03372915
Start Date
January 31 2018
End Date
December 1 2020
Last Update
December 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital Colorado
Aurora, Colorado, United States, 80045